NCT07533812 (STePS-Ai) is a NA clinical trial of Ai chatbot in Social Anxiety Disorder (SAD), sponsored by Stockholm University.

Who is sponsoring NCT07533812?

NCT07533812 is sponsored by Stockholm University.

What drugs are being tested in NCT07533812?

Interventions in NCT07533812: Ai chatbot.

What condition does NCT07533812 study?

NCT07533812 studies Social Anxiety Disorder (SAD).

Is NCT07533812 still recruiting?

NCT07533812 is currently active, enrolled. Last updated 16 April 2026.

Last reviewed 2026-04-16 · How we verify

NCT07533812: STePS-Ai

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AI-Assisted 4-Week Psychodynamic Therapy and Cognitive Behavioral Therapy Via Smartphone for Social Anxiety: A Randomized Pilot Study (STePS-Ai)

Active, enrolled NA Last updated 16 April 2026

What this trial tests

NA trial testing Ai chatbot in Social Anxiety Disorder (SAD) in 90 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

21 April 2025

Primary endpoint
21 June 2025

1 July 2026

Quick facts

Lead sponsor	Stockholm University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	90
Start date	21 April 2025
Primary completion	21 June 2025
Estimated completion	1 July 2026
Sites	1 location across Sweden

Drugs / interventions tested

Ai chatbot

Conditions studied

Social Anxiety Disorder (SAD) — all drugs for Social Anxiety Disorder (SAD) →

Sponsor

Stockholm University

Who can join

18 and older, any sex, with Social Anxiety Disorder (SAD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study compares two 4-week, smartphone-based treatments for social anxiety: one uses a psychodynamic therapy approach and the other uses a cognitive behavioral therapy approach. Both treatments are guided by an AI assistant rather than a human therapist. The AI assistant is programmed to support participants in reflecting on core therapeutic principles, much like a well-informed coach would. Participants are randomly assigned to one of three groups: psychodynamic therapy with AI support, cognitive behavioral therapy with AI support, or a waitlist control. Those in the waitlist group can receive an active treatment after the 4-week waiting period. All participants complete weekly online questionnaires to monitor anxiety and any changes in mood or well-being.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Social Anxiety Disorder (SAD)

Currently open trials in the same condition.

NCT07228143 — Stepped Care Treatment for Anxiety Resilience · NA · recruiting
NCT07466277 — Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Social Anxiety Disorder · NA · recruiting
NCT06901128 — The Covideo Study - a Trial of Cognitive Therapy for Social Anxiety Disorder in Youth, Comparing Screen to Office Delive · NA · recruiting
NCT06805565 — A Study of ONO-1110 in Patients With Social Anxiety Disorder · Phase 2 · active not recruiting
NCT07456631 — ACTsocially: The (Dis)Similarities of ACT for Changing Internalizing and Externalizing Symptomatology in Adolescence · NA · recruiting

Other Stockholm University trials

Trials by the same sponsor.

NCT03624400 — Internet-delivered Cognitive Behaviour Therapy for Sleep Problems in ASD · NA · not yet recruiting
NCT06533735 — Parent Web - Support for Families With Young People · NA · recruiting
NCT05172297 — Internet-based Universal Parent Training as a Booster to PATHS®: Parent Web · NA · completed
NCT05598970 — Family and Childhood Development: The Next Generation ('Kizazi Kijacho') · NA · completed
NCT05509309 — Promoting Inclusive Educational Environments for Children with Autism and Other Social-communication Challenges: Prescho · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07533812 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stockholm University
Last refreshed: 16 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07533812.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing